Rottinghaus Scott T. - 08 Aug 2023 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Chief Medical Officer
Signature
/s/ Matthew Kowalsky as attorney-in-fact
Issuer symbol
ENTA
Transactions as of
08 Aug 2023
Net transactions value
-$43,939
Form type
4
Filing time
09 Aug 2024, 17:24:47 UTC
Previous filing
28 Nov 2022
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Tax liability $25,276 -1,467 -5.4% $17.23 25,533 08 Aug 2023 Direct F1, F2
transaction ENTA Common Stock Tax liability $18,662 -1,466 -7.2% $12.73 18,784 08 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.
F2 Such amount excludes securities acquired or disposed of subsequent to August 8, 2023.

Remarks:

Exhibit 24 Power of Attorney filed herewith.